Clinical trial NCT04729179 - References

Fibromyalgia — Cannabidiol for Fibromyalgia (The CANNFIB Trial)

Citation(s)

•   (2020) Epidyolex Summary of product characteristics
  
•   Ablin JN, Buskila D
  Emerging therapies for fibromyalgia: an update. Expert Opin Emerg Drugs. 2010 Sep;15(3):521-33. doi: 10.1517/14728214.2010.491509.
•   Amris K, Waehrens EE, Jespersen A, Bliddal H, Danneskiold-Samsoe B
  Observation-based assessment of functional ability in patients with chronic widespread pain: a cross-sectional study. Pain. 2011 Nov;152(11):2470-2476. doi: 10.1016/j.pain.2011.05.027. Epub 2011 Jun 28.
•   Bandak E, Amris K, Bliddal H, Danneskiold-Samsoe B, Henriksen M
  Muscle fatigue in fibromyalgia is in the brain, not in the muscles: a case-control study of perceived versus objective muscle fatigue. Ann Rheum Dis. 2013 Jun;72(6):963-6. doi: 10.1136/annrheumdis-2012-202340. Epub 2012 Dec 8.
•   Banerjee S, McCormack S
  Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jul 24. Available from http://www.ncbi.nlm.nih.gov/books/NBK546424/
•   Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL
  The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10. Erratum In: Arthritis Res Ther. 2009;11(5):415.
•   Bifulco M, Pisanti S
  Medicinal use of cannabis in Europe: the fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use. EMBO Rep. 2015 Feb;16(2):130-2. doi: 10.15252/embr.201439742. Epub 2015 Jan 9. No abstract available.
•   Bramness JG, Dom G, Gual A, Mann K, Wurst FM
  A Survey on the Medical Use of Cannabis in Europe: A Position Paper. Eur Addict Res. 2018;24(4):201-205. doi: 10.1159/000492757. Epub 2018 Aug 22.
•   Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D
  Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287-333. doi: 10.1016/j.ejpain.2005.06.009. Epub 2005 Aug 10.
•   Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ
  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.
•   Choy EH, Arnold LM, Clauw DJ, Crofford LJ, Glass JM, Simon LS, Martin SA, Strand CV, Williams DA, Mease PJ
  Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol. 2009 Oct;36(10):2330-4. doi: 10.3899/jrheum.090368.
•   Coster L, Kendall S, Gerdle B, Henriksson C, Henriksson KG, Bengtsson A
  Chronic widespread musculoskeletal pain - a comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain. 2008 Jul;12(5):600-10. doi: 10.1016/j.ejpain.2007.10.001. Epub 2007 Nov 19.
•   de Wit MP, Berlo SE, Aanerud GJ, Aletaha D, Bijlsma JW, Croucher L, Da Silva JA, Glusing B, Gossec L, Hewlett S, Jongkees M, Magnusson D, Scholte-Voshaar M, Richards P, Ziegler C, Abma TA
  European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis. 2011 May;70(5):722-6. doi: 10.1136/ard.2010.135129. Epub 2011 Jan 20.
•   Drug Enforcement Administration, Department of Justice
  Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-transtetrahydrocannabinol (delta-9-THC)] in Schedule II. Interim final rule, with request for comments. Fed Regist. 2017 Mar 23;82(55):14815-20.
•   EuroQol Group
  EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.
•   Fisher, A
  G. (2010) Assessment of Motor and Process Skills: Development, Standardization, and Administration Manual. Fort Collins, Colorado: Three Star Press.
•   Fiz J, Duran M, Capella D, Carbonell J, Farre M
  Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS One. 2011 Apr 21;6(4):e18440. doi: 10.1371/journal.pone.0018440.
•   Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Dore C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E
  Guidelines for the Content of Statistical Analysis Plans in Clinical Trials. JAMA. 2017 Dec 19;318(23):2337-2343. doi: 10.1001/jama.2017.18556.
•   Greenwich Biosciences I (2020) Epidiolex Highlights of Prescibing Information
  
•   Habib G, Artul S
  Medical Cannabis for the Treatment of Fibromyalgia. J Clin Rheumatol. 2018 Aug;24(5):255-258. doi: 10.1097/RHU.0000000000000702.
•   Hallberg LR, Carlsson SG
  Coping with fibromyalgia. A qualitative study. Scand J Caring Sci. 2000;14(1):29-36. doi: 10.1111/j.1471-6712.2000.tb00558.x.
•   Hauser W, Urrutia G, Tort S, Uceyler N, Walitt B
  Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD010292. doi: 10.1002/14651858.CD010292.
•   Hauser W, Walitt B, Fitzcharles MA, Sommer C
  Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther. 2014 Jan 17;16(1):201. doi: 10.1186/ar4441.
•   Hauser W, Wolfe F, Tolle T, Uceyler N, Sommer C
  The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs. 2012 Apr 1;26(4):297-307. doi: 10.2165/11598970-000000000-00000.
•   Henry JD, Crawford JR
  The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39. doi: 10.1348/014466505X29657.
•   Iffland K, Grotenhermen F
  An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis Cannabinoid Res. 2017 Jun 1;2(1):139-154. doi: 10.1089/can.2016.0034. eCollection 2017.
•   ImpediMed, SFB7 (2020) ImpediMed
  
•   Jespersen A, Dreyer L, Kendall S, Graven-Nielsen T, Arendt-Nielsen L, Bliddal H, Danneskiold-Samsoe B
  Computerized cuff pressure algometry: A new method to assess deep-tissue hypersensitivity in fibromyalgia. Pain. 2007 Sep;131(1-2):57-62. doi: 10.1016/j.pain.2006.12.012. Epub 2007 Jan 25.
•   Jones GT, Atzeni F, Beasley M, Fluss E, Sarzi-Puttini P, Macfarlane GJ
  The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015 Feb;67(2):568-75. doi: 10.1002/art.38905.
•   Lov om forsøgsordning med medicinsk cannabis
  https://www.retsinformation.dk/Forms/R0710.aspx?id=196748 (2018).
•   Lynch ME, Campbell F
  Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011 Nov;72(5):735-44. doi: 10.1111/j.1365-2125.2011.03970.x.
•   Millar SA, Stone NL, Yates AS, O'Sullivan SE
  A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Front Pharmacol. 2018 Nov 26;9:1365. doi: 10.3389/fphar.2018.01365. eCollection 2018.
•   Moore AR, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ
  Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain. 2010 May;149(2):360-364. doi: 10.1016/j.pain.2010.02.039. Epub 2010 Mar 26.
•   Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ
  Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012 Dec 12;12:CD008242. doi: 10.1002/14651858.CD008242.pub2.
•   Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ
  Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007076. doi: 10.1002/14651858.CD007076.pub2.
•   Morales P, Hernandez-Folgado L, Goya P, Jagerovic N
  Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update. Expert Opin Ther Pat. 2016 Jul;26(7):843-56. doi: 10.1080/13543776.2016.1193157. Epub 2016 Jun 7.
•   Nabilone
  https://pubchem.ncbi.nlm.nih.gov/compound/Nabilone#section=Top (2018)
•   Nicholas MK
  The pain self-efficacy questionnaire: Taking pain into account. Eur J Pain. 2007 Feb;11(2):153-63. doi: 10.1016/j.ejpain.2005.12.008. Epub 2006 Jan 30.
•   Nielsen MG, Ornbol E, Vestergaard M, Bech P, Larsen FB, Lasgaard M, Christensen KS
  The construct validity of the Perceived Stress Scale. J Psychosom Res. 2016 May;84:22-30. doi: 10.1016/j.jpsychores.2016.03.009. Epub 2016 Mar 16.
•   Pertwee RG
  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008 Jan;153(2):199-215. doi: 10.1038/sj.bjp.0707442. Epub 2007 Sep 10.
•   Piper BJ, Beals ML, Abess AT, Nichols SD, Martin MW, Cobb CM, DeKeuster RM
  Chronic pain patients' perspectives of medical cannabis. Pain. 2017 Jul;158(7):1373-1379. doi: 10.1097/j.pain.0000000000000899.
•   Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, Currier GW, Melvin GA, Greenhill L, Shen S, Mann JJ
  The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011 Dec;168(12):1266-77. doi: 10.1176/appi.ajp.2011.10111704.
•   Pro
  medicin Information til sundhedsfaglige (2018) Sativex. https://pro.medicin.dk/Medicin/Praeparater/6456.
•   Rasmussen MU, Rydahl-Hansen S, Amris K, Samsoe BD, Mortensen EL
  The adaptation of a Danish version of the Pain Self-Efficacy Questionnaire: reliability and construct validity in a population of patients with fibromyalgia in Denmark. Scand J Caring Sci. 2016 Mar;30(1):202-10. doi: 10.1111/scs.12232. Epub 2015 Apr 29.
•   Sens Motion (2020) Discrete Wearable Acticity Sensor for Healthcare and Research
  
•   Sjogren P, Ekholm O, Peuckmann V, Gronbaek M
  Epidemiology of chronic pain in Denmark: an update. Eur J Pain. 2009 Mar;13(3):287-92. doi: 10.1016/j.ejpain.2008.04.007. Epub 2008 Jun 10.
•   Smith HS, Bracken D, Smith JM
  Pharmacotherapy for fibromyalgia. Front Pharmacol. 2011 Mar 31;2:17. doi: 10.3389/fphar.2011.00017. eCollection 2011.
•   Smith HS, Harris R, Clauw D
  Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011 Mar-Apr;14(2):E217-45.
•   Ste-Marie PA, Fitzcharles MA, Gamsa A, Ware MA, Shir Y
  Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia. Arthritis Care Res (Hoboken). 2012 Aug;64(8):1202-8. doi: 10.1002/acr.21732.
•   Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, Murnion B, Farrell M, Weier M, Degenhardt L
  Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 2018 Oct;159(10):1932-1954. doi: 10.1097/j.pain.0000000000001293.
•   Sundhedsstyrelsen, Callesen H, von Bülow C, Birkefoss K, Rasmussen M (2018) Nationale kliniske retningslinjer for udredning og behandling samt rehabilitering af patienter med genrelaliserede smerter i bevægeapparatet
  https://www.sst.dk/da/udgivelser/2018/~/media/82268C6BAF19461399C4FC8D1647DCC0.ashx.
•   Temple LM
  Medical marijuana and pain management. Dis Mon. 2016 Sep;62(9):346-52. doi: 10.1016/j.disamonth.2016.05.014. Epub 2016 Jun 27. No abstract available.
•   Tort S, Urrutia G, Nishishinya MB, Walitt B
  Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD009807. doi: 10.1002/14651858.CD009807.
•   Uceyler N, Sommer C, Walitt B, Hauser W
  Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2013 Oct 16;(10):CD010782. doi: 10.1002/14651858.CD010782.
•   Van Uum SH, Sauve B, Fraser LA, Morley-Forster P, Paul TL, Koren G
  Elevated content of cortisol in hair of patients with severe chronic pain: a novel biomarker for stress. Stress. 2008 Nov;11(6):483-8. doi: 10.1080/10253890801887388.
•   Waehrens EE, Bliddal H, Danneskiold-Samsoe B, Lund H, Fisher AG
  Differences between questionnaire- and interview-based measures of activities of daily living (ADL) ability and their association with observed ADL ability in women with rheumatoid arthritis, knee osteoarthritis, and fibromyalgia. Scand J Rheumatol. 2012 Mar;41(2):95-102. doi: 10.3109/03009742.2011.632380. Epub 2012 Jan 30.
•   Walitt B, Klose P, Fitzcharles MA, Phillips T, Hauser W
  Cannabinoids for fibromyalgia. Cochrane Database Syst Rev. 2016 Jul 18;7(7):CD011694. doi: 10.1002/14651858.CD011694.pub2.
•   Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F
  The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey. PLoS One. 2015 Sep 17;10(9):e0138024. doi: 10.1371/journal.pone.0138024. eCollection 2015.
•   Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice AS, Lunn MP, Hamunen K, Haanpaa M, Kalso EA
  Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2013 Nov 11;2013(11):CD010567. doi: 10.1002/14651858.CD010567.pub2.
•   Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, Diebold MR, Morley JE
  Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005 Nov;82(5):1074-81. doi: 10.1093/ajcn/82.5.1074.
•   Wise J
  FDA approves its first cannabis based medicine. BMJ. 2018 Jun 27;361:k2827. doi: 10.1136/bmj.k2827. No abstract available.
•   Wolfe F, Brahler E, Hinz A, Hauser W
  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken). 2013 May;65(5):777-85. doi: 10.1002/acr.21931.
•   Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al
  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72. doi: 10.1002/art.1780330203.

Cannabidiol for Fibromyalgia -The CANNFIB Trial Protocol for a Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial

Details for clinical trial NCT04729179